| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/23/1992 | CA1303990C Solubilization of hydrophobic materials using lysophospholipids |
| 06/23/1992 | CA1303987C Pharmaceutical composition having thrombolytic activity |
| 06/23/1992 | CA1303986C Anti-proliferative action of dsrnas on tumor cells |
| 06/23/1992 | CA1303980C Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies and use therefor |
| 06/22/1992 | WO1992011364A1 Biosynthetic pdgf antagonists |
| 06/22/1992 | WO1992011290A1 Medicaments for the treatment of papillomavirus diseases |
| 06/22/1992 | WO1992011024A1 Use of hirudine and its muteines and their peg derivatives for the combined treatment of tumours |
| 06/22/1992 | WO1992011021A1 Angiogenic peptides |
| 06/22/1992 | CA2098926A1 Medicaments for the treatment of papillomavirus diseases |
| 06/22/1992 | CA2098922A1 Neuronal cholinergic differentiation factor |
| 06/22/1992 | CA2098707A1 Use of hirudin, its muteins and the peg derivatives thereof for the combination treatment of tumors |
| 06/22/1992 | CA2097603A1 Biosynthetic pdgf antagonists |
| 06/22/1992 | CA2058247A1 Tert-butyloxcarbonyl-1-tyrosyl-peptidoglycan monomer and 1251-labelled derivative thereof, their preparation and use |
| 06/22/1992 | CA2058168A1 New use of peptide derivative |
| 06/22/1992 | CA2055984A1 Synergistic effect of lantibiotics in combination with selected agents against gram negative bacteria |
| 06/21/1992 | WO1992011120A1 Method and apparatus for granulation |
| 06/21/1992 | CA2098600A1 Method and apparatus for granulation |
| 06/21/1992 | CA2057972A1 Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
| 06/20/1992 | WO1992011030A1 Use of il-4 to enhance immune response to immunogens in vaccines |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/20/1992 | CA2098726A1 Use of il-4 to enhance immune response to immunogens in vaccines |
| 06/19/1992 | WO1992011377A1 Tissue plasminogen activator substitution variant |
| 06/19/1992 | WO1992011360A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 06/19/1992 | WO1992011034A1 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| 06/19/1992 | CA2098484A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 06/19/1992 | CA2098198A1 Agents for potentiating the effects of antitumour agents and combating multiple drug resistance |
| 06/19/1992 | CA2057951A1 Chimeric antibodies and their use |
| 06/18/1992 | WO1992011356A1 Thrombolytic peptide, production thereof and thrombolytic agent |
| 06/18/1992 | WO1992011282A1 Polypeptide fraction affording protection to cells against mechanical damage and assay |
| 06/18/1992 | CA2076001A1 Polypeptide fraction affording protection to cells against mechanical damage and assay |
| 06/18/1992 | CA2057646A1 Benzodiazepinone |
| 06/17/1992 | EP0490806A2 Nasal pharmaceutical compositions |
| 06/17/1992 | EP0490667A2 HIV protease inhibitors |
| 06/17/1992 | EP0490549A1 Stabilisation of pharmaceutical compositions comprising calcitonin |
| 06/17/1992 | EP0490384A1 Process for the production of pasteurized and iron-free human transferrin |
| 06/17/1992 | EP0490383A2 Peptides of the HIV-gag protein, their preparation and use |
| 06/17/1992 | EP0490379A2 Diamino acid derivatives and pharmaceutical compositions |
| 06/17/1992 | EP0490259A2 Aminoacid and peptid derivatives with renin inhibiting properties |
| 06/17/1992 | EP0490250A2 Use of interferon and an antimalarial agent for the treatment of malarial infections |
| 06/17/1992 | EP0490249A1 Process for the enzymatic preparation of GRF(1-44)NH2 |
| 06/17/1992 | EP0490077A1 Antisense oligonucleotides for treatment of cancer |
| 06/17/1992 | EP0490006A1 Pharmaceutical compositions for the treatment of B-cell malignancies |
| 06/17/1992 | EP0489846A1 Antisense oligonucleotides to c-abl proto-oncogene |
| 06/17/1992 | EP0489837A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
| 06/17/1992 | EP0489836A1 Light activated acyl-enzymes. |
| 06/17/1992 | EP0489830A1 Expression of alpha-macroglobulins |
| 06/17/1992 | EP0479922A4 Monoclonal antibodies to c-reactive protein |
| 06/17/1992 | EP0357637B1 General cancer-associated scm-recognition factor, preparation and method of use |
| 06/17/1992 | EP0215131B1 E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma |
| 06/17/1992 | DE4040184A1 New di:aminoacid derivs., e.g. lysine-proline |
| 06/17/1992 | DE4039656A1 Arzneimittel, enthaltend das humane parathormon-fragment (1-37) in der form des amids oder ethylamids als aktiven wirkstoff A medicament containing the human parathyroid hormone fragment (1-37) in the form of the amide or ethylamids as an active ingredient |
| 06/17/1992 | DE4039589A1 New hydroxy-acyl deca:peptide derivs. - are antiproliferative and antiinflammatory agents used to treat e.g. dermatitis |
| 06/17/1992 | CN1061971A Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 06/16/1992 | US5122614 Stable, hydrolysis resistant linkages |
| 06/16/1992 | US5122610 Renin inhibitor intermediates |
| 06/16/1992 | US5122599 CDNAS coding for members of the carcinoembryonic antigen family |
| 06/16/1992 | US5122597 Application of resins consisting of functional polymers as the stationary phase in affinity chromatography for the purification of growth factors, and corresponding purification method |
| 06/16/1992 | US5122596 Polypeptides useful as blockers of calcium channels |
| 06/16/1992 | US5122594 Having specific arginines replaced by glutamine and/or serine |
| 06/16/1992 | US5122515 Nutrient composition containing dipeptides and method for administering the same |
| 06/16/1992 | US5122514 Psoriasis treatment |
| 06/16/1992 | US5122513 Fish growth using bovine placental lactogen |
| 06/16/1992 | US5122512 Swine growth promoting composition |
| 06/16/1992 | US5122511 Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| 06/16/1992 | US5122376 Calcitonin gene related peptide |
| 06/16/1992 | US5122373 Immunoglobulin-g-containing fraction |
| 06/16/1992 | US5122372 Process for treatment of allergies |
| 06/16/1992 | US5122367 Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone |
| 06/16/1992 | CA1303627C Nona and decapeptide analogs of lhrh useful as lhrh antagonists |
| 06/16/1992 | CA1303534C Human anti-rh(d) monoclonal antibodies |
| 06/16/1992 | CA1303533C Human anti-rh(d) monoclonal antibodies |
| 06/16/1992 | CA1303530C EXPRESSION VECTORS AND THEIR USE FOR THE PREPARATION OF A PROTEIN HAVING HUMAN .alpha. -ANTITRYPSIN ACTIVITY |
| 06/16/1992 | CA1303529C Human interferon- _polypeptide derivative |
| 06/15/1992 | WO1992010506A1 Human retrovirus receptor and dna coding therefor |
| 06/15/1992 | WO1992010207A1 Oral administration of alpha interferon to treat lung malignancies |
| 06/15/1992 | WO1992010204A1 Lectins in probiosis |
| 06/15/1992 | CA2098393A1 Oral administration of alpha interferon to treat lung malignancies |
| 06/15/1992 | CA2098305A1 Lectins in probiosis |
| 06/15/1992 | CA2097705A1 Human retrovirus receptor and dna coding therefor |
| 06/15/1992 | CA2057534A1 Acid amides |
| 06/14/1992 | WO1992010576A1 Fusion polypeptides |
| 06/14/1992 | WO1992010570A1 Leukemia inhibitory factor receptors |
| 06/14/1992 | WO1992010201A1 Pharmaceutical compositions for the treatment of b-cell malignancies |
| 06/14/1992 | CA2098509A1 Pharmaceutical compositions for the treatment of b-cell malignancies |
| 06/14/1992 | CA2097291A1 Leukemia inhibitory factor receptors |
| 06/14/1992 | CA2094512A1 Fusion polypeptides |
| 06/14/1992 | CA2057601A1 Pharmaceutical use of diamino acid derivatives |
| 06/11/1992 | WO1992010582A1 Monokine mig induced by ifn-gamma |
| 06/11/1992 | WO1992009893A1 DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS AND METHODS FOR LIPOPROTEIN(a) |
| 06/11/1992 | WO1992009701A1 Analytical tracers for cancer, particularly malignant breast cancer |
| 06/11/1992 | WO1992009697A1 USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-β FOR BONE REPAIR |
| 06/11/1992 | WO1992009693A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same |
| 06/11/1992 | WO1992009691A1 New variants derived from interferons of type i, production process thereof and their applications |
| 06/11/1992 | WO1992009634A1 Non-a non-b hepatitis virus antigen protein |
| 06/11/1992 | WO1992009629A1 Protein presenting an activity of the cytokine type, recombinant dna, expression vector and hosts used to produce such protein |
| 06/11/1992 | WO1992009628A1 Synthetic immunoactive peptides having immunomodulating and therapeutic activities |
| 06/11/1992 | WO1992009626A1 Nonapeptide bombesin antagonists |
| 06/11/1992 | WO1992009625A1 Conformationally constrained peptides i |
| 06/11/1992 | WO1992009624A1 Novel renin inhibiting peptides |
| 06/11/1992 | WO1992009621A1 Biologically active bactericidal/permeability-increasing protein fragments |